Breaking News Instant updates and real-time market news.

TEVA

Teva

$45.26

-0.42 (-0.92%)

07:12
10/05/16
10/05
07:12
10/05/16
07:12

Teva estimates lowered on generic trends at Wells Fargo

Wells Fargo analyst David Maris lowered his estimates for Teva (TEVA) for this year and next, citing expectations for lower generic sales this year and lower margins in the generic business. Maris lowered his price target range for Teva shares to $60-$61 from $70-73 based on his lower estimates as well as the uncertainty of the environment, but keeps an Outperform rating on shares citing valuation and his belief 2017 should be a better year with several pipeline events for Teva.

  • 06

    Nov

  • 15

    Nov

TEVA Teva
$45.26

-0.42 (-0.92%)

09/21/16
ROTH
09/21/16
NO CHANGE
Target $520
ROTH
Buy
Teva deal important for Regeneron, says at Roth Capital
Roth Capital analyst Joseph Pantginis points out that Regeneron (REGN) has signed a global partnership for fasinumab with Teva (TEVA), which he sees as an important new partnership for the former both on the product development front as well as a significant next step for fasinumab and the anti-NGF class of drugs. The analyst believes Regeneron has solid growth prospects and upside potential, and reiterates a Buy rating and $520 price target on the shares.
09/23/16
LEER
09/23/16
NO CHANGE
LEER
Outperform
Positive data paves way for Teva SD-809 indication, says Leerink
Leerink analyst Jason Gerberry says the AIM-TD study readout clinically de-risks Teva's (TEVA) SD-809 opportunity for tardive dyskinesia, with the investor focus shifting to market size and competitive differentiation versus Neurocrine's (NBIX) valbenazine. The analyst believes Teva's SD-809 is well positioned to compete against valbenazine with an equally efficacious and well tolerated drug. Further, he expects Teva to exit 2017 with a broader label. Gerberry reiterates an Outperform rating on Teva's shares.
09/29/16
OTRG
09/29/16
INITIATION
OTRG
Positive
Teva initiated with a Positive at OTR Global
10/03/16
WELS
10/03/16
NO CHANGE
WELS
Outperform
Teva shares suffering from lack of catalysts, says Wells Fargo
Wells Fargo analyst David Maris attributes the continued slide in Teva (TEVA) shares largely to negative sector news such as the drug pricing debate, fears on generic pricing, and Mylan's (MYL) EpiPen issue, but also thinks the slide has been made worse by Teva's lack of near-term catalysts. Additionally, the ongoing Copaxone generic trial and Teva's recently filed suit against Rimsa's founders over allegedly being misled by the Mexican pharmaceutical company have added to the pressure, Maris noted. Maris acknowledges there may be "no notable catalysts" for the rest of the year for Teva, but he thinks it should be a "robust 2017" for the company and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

GRUB

GrubHub

$47.70

1.37 (2.96%)

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

07:58
06/26/17
06/26
07:58
06/26/17
07:58
Downgrade
GrubHub, Amazon.com rating change  »

GrubHub downgraded to…

GRUB

GrubHub

$47.70

1.37 (2.96%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

AAPL

Apple

$146.28

0.65 (0.45%)

07:57
06/26/17
06/26
07:57
06/26/17
07:57
Periodicals
Apple hires Stanford researcher for digital health, Digital Commerce 360 says »

Apple has hired Sumbul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NBHC

National Bank

$31.55

-0.18 (-0.57%)

07:57
06/26/17
06/26
07:57
06/26/17
07:57
Hot Stocks
National Bank acquires Peoples in $143M transaction »

National Bank and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

07:56
06/26/17
06/26
07:56
06/26/17
07:56
Recommendations
Portola Pharmaceuticals analyst commentary  »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOXX

VOXX

$7.85

0.25 (3.29%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Hot Stocks
Breaking Hot Stocks news story on VOXX »

VOXX trading halted, news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEOT

Neothetics

$2.32

0.0501 (2.21%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Hot Stocks
Breaking Hot Stocks news story on Neothetics »

Neothetics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHM

Autohome

$45.47

-0.15 (-0.33%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Conference/Events
Autohome to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NSU

Nevsun Resources

$2.27

-0.02 (-0.87%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Hot Stocks
Nevsun Resources names Ian Pearce as Board Chair, effective June 30 »

Nevsun Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPLX

MPLX

$32.02

0.9 (2.89%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Hot Stocks
MPLX sees FY17 net income $550M-$700M, adjusted EBITDA $1.7B-$1.85B »

Sees FY net cash provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

REGN

Regeneron

$517.33

-9.2 (-1.75%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Downgrade
Regeneron rating change  »

Regeneron downgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKBA

Akebia

$16.35

-0.14 (-0.85%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Conference/Events
Akebia to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

, KHC

Kraft Heinz

$88.85

-0.25 (-0.28%)

07:49
06/26/17
06/26
07:49
06/26/17
07:49
Periodicals
Packaged food companies face pressure from Amazon's grocery plans, WSJ says »

Amazon's (AMZN) move…

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

KHC

Kraft Heinz

$88.85

-0.25 (-0.28%)

K

Kellogg

$70.56

0.15 (0.21%)

MDLZ

Mondelez

$44.90

0.05 (0.11%)

CPB

Campbell Soup

$53.58

-0.37 (-0.69%)

CAG

Conagra Brands

$37.23

0.14 (0.38%)

WFM

Whole Foods

$42.95

-0.255 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 29

    Jun

COST

Costco

$157.13

-2.66 (-1.66%)

07:49
06/26/17
06/26
07:49
06/26/17
07:49
Technical Analysis
Technical View: Costco rises in pre-market, analyst action »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

ZTO

ZTO Express

$14.34

0.08 (0.56%)

07:48
06/26/17
06/26
07:48
06/26/17
07:48
Initiation
ZTO Express initiated  »

ZTO Express initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$31.73

-0.16 (-0.50%)

07:48
06/26/17
06/26
07:48
06/26/17
07:48
Recommendations
Micron analyst commentary  »

Micron multiple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 29

    Aug

COH

Coach

$46.71

0.23 (0.49%)

07:47
06/26/17
06/26
07:47
06/26/17
07:47
Upgrade
Coach rating change  »

Coach upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCIT

NCI, Inc.

$20.40

-0.15 (-0.73%)

07:47
06/26/17
06/26
07:47
06/26/17
07:47
Recommendations
NCI, Inc. analyst commentary  »

NCI, Inc. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$119.56

-0.15 (-0.13%)

07:47
06/26/17
06/26
07:47
06/26/17
07:47
Recommendations
Philip Morris analyst commentary  »

Philip Morris Q1 double…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JHG

Janus Henderson Group

$32.90

-0.19 (-0.57%)

07:45
06/26/17
06/26
07:45
06/26/17
07:45
Initiation
Janus Henderson Group initiated  »

Janus Henderson Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:45
06/26/17
06/26
07:45
06/26/17
07:45
General news
Treasury Market Outlook: bonds are mixed »

Treasury Market Outlook:…

KIN

Kindred Biosciences

$8.25

0.35 (4.43%)

07:44
06/26/17
06/26
07:44
06/26/17
07:44
Conference/Events
Kindred Biosciences to host business news update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 30

    Jun

  • 26

    Sep

TMST

TimkenSteel

$13.48

0.15 (1.13%)

07:44
06/26/17
06/26
07:44
06/26/17
07:44
Recommendations
TimkenSteel analyst commentary  »

TimkenSteel weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WING

Wingstop

$30.94

0.53 (1.74%)

07:43
06/26/17
06/26
07:43
06/26/17
07:43
Recommendations
Wingstop analyst commentary  »

Wingstop reiterated as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$146.28

0.65 (0.45%)

07:41
06/26/17
06/26
07:41
06/26/17
07:41
Recommendations
Apple analyst commentary  »

Apple growth in China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

07:39
06/26/17
06/26
07:39
06/26/17
07:39
Downgrade
Agios Pharmaceuticals rating change  »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.